Shortness Of Breath in Lung Cancer
| ISRCTN | ISRCTN49387307 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN49387307 |
| Protocol serial number | Version 2 |
| Sponsor | Hull and East Yorkshire Hospitals NHS Trust (HEYHT) (UK) |
| Funder | National Institute for Health Research |
- Submission date
- 25/08/2010
- Registration date
- 25/01/2011
- Last edited
- 25/10/2022
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Cancer
Plain English summary of protocol
Contact information
Scientific
St. Catherine's Hospice
Throxenby Lane
North Yorkshire
Scarborough
YO12 5RE
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Multicentre randomised controlled non-blinded parallel-group study |
| Secondary study design | Randomised parallel trial |
| Study type | Participant information sheet |
| Scientific title | A randomised trial of high versus low intensity training in breathing techniques for breathlessness in patients with malignant lung disease: early intervention |
| Study acronym | SOB-LC II |
| Study objectives | Three breathing training sessions at weekly intervals are more effective than a single session in reducing the breathlessness severity of patients with intra-thoracic malignancy and refractory breathlessness. Please note that this record is related to a previously registered trial entitled "Breathlessness training: comparison of two programmes for Shortness Of Breath in Lung Cancer" (ISRCTN62865905), and can be found at http://www.isrctn.com/ISRCTN62865905. |
| Ethics approval(s) | Sheffield Research Ethics Committee, 15/12/2010, ref: 10/H1308/66 |
| Health condition(s) or problem(s) studied | Intrathoracic cancer |
| Intervention | Patients randomised to the single session training arm will be taught the four techniques of management of breathlessness (breathing control, pacing, anxiety management and relaxation) at a single session in a clinical setting appropriate to the needs of the patient by the therapist. Patients randomised to the three session training arm will be taught the same four techniques of the management of breathlessness at a single session in a clinical setting appropriate to the needs of the patient by the therapist. This will be followed by practice and reinforcement face-to-face with the therapist on two further occasions at weekly intervals. Both groups will receive written reinforcement in the form of information booklets plus verbal reinforcement in the format of the patients choice (CD, video or DVD) will be given to remind the patient of the techniques they have been taught. One week after the final visit, the therapist will ring the patient to see if they have remembered to practise the techniques and if they have managed to watch/listen to the reinforcement information. The primary analysis point is a 4 weeks, but participants will be followed up until 8 weeks. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
Worst severity of breathlessness over past 24 hours measured by NRS |
| Key secondary outcome measure(s) |
1. Breathlessness score on NRS (severity: average over last 24 hours) |
| Completion date | 31/03/2013 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 146 |
| Total final enrolment | 156 |
| Key inclusion criteria | 1. Primary or secondary malignant lung disease 2. Aged over 18 years 3. Willingness to engage with breathlessness training 4. Ability to give informed consent 5. Sufficient understanding of the English language to complete the study questionnaires 6. Severity average breathlessness (Numeric Rating Scale [NRS]) greater than 3 7. All identified reversible causes of the breathlessness have been treated if appropriate to do so, in the opinion of the attending clinician 8. Verbal confirmation of consent 9. Estimated prognosis (in the investigator's opinion) of greater than 3 months |
| Key exclusion criteria | 1. Inability to give informed consent 2. Intercurrent illness or co-morbidities making completion of the study unlikely 3. Rapidly worsening breathlessness requiring urgent medical intervention 4. Insufficient understanding of the English language to complete the study questionnaires 5. Verbal withdrawal of consent 6. Unable to complete study assessments |
| Date of first enrolment | 25/05/2011 |
| Date of final enrolment | 31/03/2013 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
YO12 5RE
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan | Not provided at time of registration |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | cost-effectiveness results | 01/11/2014 | Yes | No | |
| Results article | results | 07/09/2015 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Plain English results | 25/10/2022 | No | Yes |
Editorial Notes
25/10/2022: Cancer Research UK plain English results link and total final enrolment added.
06/02/2017: Publication reference added.